Search for:
Sign In
New Users
|
Education
Legislative
Mentoring
News
Board
Committees
Advertising (Post an Ad)
Office & Staff
Contact Us
Links - Resources
ASC Assessment
Infection Control
Medicare
Disaster Preparedness
Drug Shortages
Infection Control
Current Issues
Legislative Updates
Tools and Tips
Member Directory
On-Line Application
My WISCA
Change Password
Member Payment
Webinar Recordings
Calendar of Events
Post your event (Event Request)
Employment Opportunities
Post your resume
Post a Job
Discussion Board
About WISCA
Advocacy
Membership
Events
Career Center
Advocacy
Drug Shortages
Infection Control
Current Issues
ASC Assessment
Infection Control
Medicare
Disaster Preparedness
Legislative Updates
Tools and Tips
ASC Association Seeks Action on Drug Shortage Issues
2/2/2012
ASC Association Government Affairs Update
February 2, 2012
Rep. Ed Whitfield (R-KY) is currently seeking members of the House of Representatives to join him in sending a letter to Secretary of Health and Human Services (HHS) Kathleen Sebelius regarding a Centers for Medicare and Medicaid Services (CMS) guideline on the use of single-use vials. Under the guideline vials that have been labeled as single-use cannot be used for multiple patients and must be discarded after use.
The CDC defines a single use vial as one that contains only one dose of medication. However, health care providers report that manufactures are increasingly labeling vials “single-use” when they actually contain several doses of medication. The requirement to follow CMS’s guidelines for these large single use vials has had the unintended effect of forcing physicians and health care facilities to waste unused portions of drugs, even some drugs that are already deemed in short supply and that are hard to obtain. Many ASCs have recently had trouble obtaining supplies of critical anesthesia drugs, such as Versed and Fentyl. The letter points out this problem and notes that “there is no evidence that transmission of blood borne pathogens during health care procedures continue to occur because of the use of single dose vials in multiple patients when appropriate sterile procedures are used.”
If you would like to contact your Member of Congress and request that they sign the Whitfield letter, please
click here
.
Letters from Members of Congress to federal agencies are a way for Congress to weigh in on regulatory matters and seek changes in the way regulations are interpreted or enforced. To read the congressional letter to Secretary Sebelius,
click here
.
For more information, contact Morgan Hanson at
mhanson@ascassociation.org
.